A Long Term Documentation to Demonstrate Long Term Efficacy and Safety of Humira in Patients With Psoriatic Arthritis Under Conditions of Daily Practice.

Trial Profile

A Long Term Documentation to Demonstrate Long Term Efficacy and Safety of Humira in Patients With Psoriatic Arthritis Under Conditions of Daily Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Psoriatic arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 12 Jun 2016 Results assessing association between anti-citrullinated protein antibodies bone destruction (n=1996) published in the Rheumatology
    • 15 Dec 2015 Results of retrospective analysis published in The Journal of Rheumatology
    • 17 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top